Sustained durability of responses and improved progression-free and overall survival with imatinib treatment for accelerated phase and blast crisis chronic myeloid leukemia: long-t...

Por Silver, Richard T., Cortes, Jorge, Waltzman, Roger, Mone, Manisha, Kantarjian, Hagop
Publicado em 2009

High rates of durable response are achieved with imatinib after treatment with interferon α plus cytarabine: results from the International Randomized Study of Interferon and STI57...

Por Guilhot, François, Druker, Brian, Larson, Richard A., Gathmann, Insa, So, Charlene, Waltzman, Roger, O’Brien, Stephen G.
Publicado em 2009